Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Atomoxetine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ATOMAID 80mg capsules
0404000S0BCABAF
|
ATOMAID | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 30mg/5ml oral suspension
0404000S0AAAPAP
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 36mg/5ml oral suspension
0404000S0AAAQAQ
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 40mg/5ml oral suspension
0404000S0AAAJAJ
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 5mg/5ml oral solution
0404000S0AAAGAG
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 5mg/5ml oral suspension
0404000S0AAAMAM
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
|
Atomoxetine 60mg/5ml oral solution
0404000S0AAANAN
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.